TMC Life Sciences Bhd (KLSE:0101) — Stock Price

RM0.48 MYR
▲ 0.00% today

TMC Life Sciences Bhd (KLSE:0101) is currently trading at RM0.48 MYR, up 0.00% today. Over the past 52 weeks, shares have ranged between RM0.40 and RM0.57. This page tracks TMC Life Sciences Bhd's live share price on the KLSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see TMC Life Sciences Bhd (0101) total market value.

TMC Life Sciences Bhd (0101) Stock Price Chart — Daily History & Trading Volume

The chart below tracks TMC Life Sciences Bhd's daily closing share price and trading volume on the KLSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

TMC Life Sciences Bhd Income Statement — Revenue, Profit & Earnings by Year

TMC Life Sciences Bhd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue RM345.54 Million RM346.42 Million RM311.44 Million RM243.77 Million RM201.02 Million
Cost of Revenue RM118.02 Million RM234.54 Million RM90.09 Million RM75.79 Million RM66.76 Million
Gross Profit RM227.52 Million RM111.88 Million RM221.35 Million RM167.99 Million RM134.26 Million
Research & Development — — — — —
SG&A RM117.93 Million RM106.08 Million RM94.49 Million RM79.85 Million RM64.62 Million
Total Operating Expenses RM219.88 Million RM56.68 Million RM178.37 Million RM137.91 Million RM109.40 Million
Operating Income RM7.64 Million RM55.20 Million RM49.38 Million RM33.92 Million RM27.91 Million
EBITDA RM50.51 Million RM90.78 Million RM76.30 Million RM50.14 Million RM41.13 Million
EBIT RM16.41 Million RM62.87 Million RM50.29 Million RM34.27 Million RM28.09 Million
Interest Expense RM9.34 Million RM10.25 Million RM9.41 Million RM2.10 Million RM441.00K
Income Before Tax RM7.07 Million RM52.62 Million RM40.89 Million RM32.18 Million RM27.67 Million
Income Tax Expense RM3.47 Million RM11.97 Million RM1.63 Million RM-9.21 Million RM7.42 Million
Net Income RM3.61 Million RM40.65 Million RM39.26 Million RM41.39 Million RM20.25 Million

TMC Life Sciences Bhd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes TMC Life Sciences Bhd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets RM1.13 Billion RM1.19 Billion RM1.18 Billion RM1.13 Billion RM1.06 Billion
Total Current Assets RM202.48 Million RM262.54 Million RM251.80 Million RM204.55 Million RM185.68 Million
Cash & Equivalents RM66.01 Million RM128.57 Million RM29.77 Million RM74.67 Million RM58.38 Million
Short-term Investments RM44.64 Million RM76.86 Million RM45.80 Million RM39.98 Million RM32.69 Million
Net Receivables RM60.18 Million RM45.95 Million RM69.71 Million RM50.48 Million RM33.16 Million
Inventory RM15.91 Million RM11.62 Million RM13.37 Million RM10.88 Million RM10.30 Million
Property, Plant & Equipment RM725.78 Million RM718.27 Million RM715.15 Million RM728.45 Million RM677.33 Million
Goodwill RM193.04 Million RM193.04 Million RM193.04 Million RM193.04 Million RM193.04 Million
Total Liabilities RM279.15 Million RM301.69 Million RM314.84 Million RM305.46 Million RM270.61 Million
Total Current Liabilities RM110.31 Million RM98.62 Million RM98.57 Million RM90.28 Million RM75.45 Million
Long-term Debt RM141.43 Million RM178.83 Million RM198.38 Million RM196.16 Million RM164.77 Million
Net Debt RM77.51 Million RM93.52 Million RM56.68 Million RM71.58 Million RM36.59 Million
Total Stockholder Equity RM853.04 Million RM888.03 Million RM861.96 Million RM827.39 Million RM789.62 Million
Retained Earnings RM227.06 Million RM260.73 Million RM234.56 Million RM199.69 Million RM159.97 Million

TMC Life Sciences Bhd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how TMC Life Sciences Bhd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow RM22.51 Million RM80.23 Million RM54.57 Million RM35.88 Million RM22.45 Million
Capital Expenditures RM41.14 Million RM28.55 Million RM34.46 Million RM68.69 Million RM103.52 Million
Free Cash Flow RM-18.63 Million RM51.68 Million RM20.11 Million RM-32.81 Million RM-81.07 Million
Investing Cash Flow RM-4.64 Million RM-59.60 Million RM-38.92 Million RM-74.36 Million RM-96.13 Million
Financing Cash Flow RM-64.55 Million RM-29.66 Million RM2.04 Million RM32.04 Million RM82.31 Million
Dividends Paid RM-38.62 Million RM-14.63 Million RM4.81 Million RM3.86 Million RM2.92 Million
Stock-Based Compensation RM19.00K RM55.00K RM127.00K RM236.00K RM202.00K
Depreciation RM34.10 Million RM27.91 Million RM26.01 Million RM15.85 Million RM13.02 Million
Change in Cash RM-46.69 Million RM-9.07 Million RM17.69 Million RM-6.44 Million RM8.63 Million

TMC Life Sciences Bhd Earnings History — EPS Actual vs. Analyst Estimates

Track TMC Life Sciences Bhd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 31, 2026 0.00 — —
Dec 31, 2025 0.00 — —
Sep 30, 2025 0.00 — —
Jun 30, 2025 0.00 — —
Mar 31, 2025 0.00 — —
Dec 31, 2024 0.00 — —
Sep 30, 2024 0.00 — —
Jun 30, 2024 0.00 — —